Decheng Capital LLC
14 holdingsFiling period: 2026-03-31Current AUM: $758.0Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | CGON | CG ONCOLOGY INC | 6.37M | $431.2M | $453.6M | 59.84% | -- | 2026-03-31 |
| 2 | NUVB | Nuvation Bio Inc. | 25.95M | $111.3M | $164.3M | 21.68% | -- | 2026-03-31 |
| 3 | UPB | Upstream Bio Inc. | 2.72M | $24.5M | $17.2M | 2.27% | -418,210 | 2026-03-31 |
| 4 | ACRS | Aclaris Therapeutics, Inc. | 4.04M | $15.2M | $21.0M | 2.77% | -- | 2026-03-31 |
| 5 | AARD | AARDVARK THERAPEUTICS INC | 3.92M | $14.8M | $25.9M | 3.41% | -- | 2026-03-31 |
| 6 | LYEL | Lyell Immunopharma, Inc. | 692.0K | $13.9M | $9.0M | 1.18% | -- | 2026-03-31 |
| 7 | — | NEWAMSTERDAM PHARMA CO NV | 325.1K | $10.4M | $10.4M | 1.37% | -267,000 | 2026-03-31 |
| 8 | RCUS | Arcus Biosciences, Inc | 477.8K | $10.3M | $13.5M | 1.78% | -63,740 | 2026-03-31 |
| 9 | RVMD | REVOLUTION MEDICINES INC(NSM) | 93.5K | $9.1M | $17.5M | 2.31% | -106,500 | 2026-03-31 |
| 10 | EQ | Equillium Inc. | 4.45M | $8.9M | $9.8M | 1.29% | -- | 2026-03-31 |
| 11 | — | BeyondSpring Inc. | 3.80M | $6.2M | $6.2M | 0.82% | -- | 2026-03-31 |
| 12 | ZNTL | Zentalis Pharmaceuticals Inc. | 1.32M | $3.1M | $6.3M | 0.83% | -- | 2026-03-31 |
| 13 | KRYS | KRYSTAL BIOTECH INC | 7.3K | $1.9M | $2.5M | 0.33% | -10,000 | 2026-03-31 |
| 14 | PYXS | Pyxis Oncology, Inc (formerly Apexigen) | 326.8K | $477K | $866K | 0.11% | -- | 2026-03-31 |
← Scroll →